薬剤溶出ステント市場 - 世界の産業規模、シェア、動向、機会、予測、コーティングタイプ別（ポリマーベースコーティング、ポリマーフリーコーティング）、用途別、地域別、競合別、2020年～2030年

薬剤溶出ステント（DES）の世界市場規模は2024年に83億米ドルとなり、2030年までのCAGRは8.08％と堅調な成長が予測されています。

世界のヘルスケア分野、特にテクノロジーとイノベーションにおける大きな進歩は、患者のケアと治療成果の向上に重要な役割を果たしています。こうした進歩の中で、薬剤溶出ステントはインターベンショナルカーディオロジーにおける革新的なソリューションとして登場しました。この小型ながら重要な医療機器は、冠動脈疾患（CAD）の管理に革命をもたらし、世界のDES市場の顕著な拡大に拍車をかけています。

薬剤溶出ステントは、冠動脈疾患を治療し、動脈再狭窄の可能性を低減するために使用される特殊な医療機器です。抗再狭窄薬でコーティングされた金属メッシュチューブで構成されるDESは、動脈の開存性を維持する構造的支持体としての機能と、薬剤を制御放出するデリバリーシステムとしての機能を併せ持ちます。この2つの機能により、狭窄または閉塞した冠動脈にDESを留置した後の再狭窄を防ぐことができます。

主要な市場促進要因

世界人口の高齢化

主要な市場課題

規制上のハードル

主要市場動向

技術の進歩

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 薬剤溶出ステント市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • コーティングタイプ別（ポリマーベースコーティング（非生分解性、生分解性）、ポリマーフリーコーティング（マイクロポーラス表面、マイクロ構造表面、スロット付き管状表面、ナノポーラス表面））
  • 用途別（冠動脈疾患、末梢動脈疾患）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の薬剤溶出ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の薬剤溶出ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の薬剤溶出ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の薬剤溶出ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの薬剤溶出ステント市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の薬剤溶出ステント市場：SWOT分析

第14章 競合情勢

• Abbott Laboratories Ltd.
• Boston Scientific Corporation
• Terumo Corporation
• Medtronic plc
• Biosensors International Ltd
• Cook Medical pvt ltd.
• B. Braun Medical（India）Private Limited
• Biotronik, Inc.
• Lepu Medical Technology Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Drug-eluting stent (DES) market was valued at USD 8.30 billion in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 8.08% through 2030. Significant advancements within the global healthcare sector-particularly in technology and innovation-have played a critical role in enhancing patient care and treatment outcomes. Among these advancements, drug-eluting stents have emerged as a transformative solution in interventional cardiology. These small yet vital medical devices are revolutionizing the management of coronary artery disease (CAD), thereby fueling notable expansion in the global DES market.

Drug-eluting stents are specialized medical devices used to treat coronary artery disease and reduce the likelihood of arterial re-narrowing. Comprising a metallic mesh tube coated with an anti-restenotic drug, DES function both as a structural support to maintain arterial patency and as a delivery system for controlled drug release. This dual function helps prevent restenosis following implantation in narrowed or blocked coronary arteries..

Key Market Drivers

Aging Global Population

The growing elderly population is a major driver of the DES market, as older individuals are more vulnerable to cardiovascular diseases, particularly CAD. With global life expectancy on the rise, demand for minimally invasive cardiac treatments is expected to increase. According to the World Health Organization, the global population aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion by 2030 and reach 2.1 billion by 2050. The 80+ age group is also set to triple, rising to 426 million by 2050. This demographic shift has far-reaching implications for healthcare providers and device manufacturers, as cardiovascular treatments such as DES become increasingly essential.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges for the DES market is the constantly evolving regulatory landscape. Regulatory bodies across various regions frequently revise guidelines governing medical devices. As a result, manufacturers must allocate significant resources to ensure ongoing compliance. Securing approvals for new or modified products can be both time-intensive and costly, potentially delaying market entry and impacting profitability.

Key Market Trends

Technological Advancements

Technological innovation is significantly reshaping the global healthcare landscape, with drug-eluting stents at the forefront of progress in interventional cardiology. One of the most notable advancements is the use of biocompatible polymers that optimize drug release kinetics and reduce adverse patient reactions such as inflammation or allergies.

In addition, bioabsorbable stents represent a cutting-edge development. Designed to gradually dissolve within the body, these stents eliminate the long-term complications often associated with permanent metal implants, such as late-stage thrombosis. These innovations are expected to enhance treatment outcomes and further stimulate market growth in the coming years.

Key Market Players

• Abbott Laboratories ltd.
• Boston Scientific Corporation
• Terumo Corporation
• Medtronic plc
• Biosensors International Ltd
• Cook Medical pvt ltd.
• B. Braun Medical (India) Private Limited
• Biotronik, Inc.
• Lepu Medical Technology Inc.

Report Scope:

In this report, the Global Drug Eluting Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Eluting Stent Market, By Coating Type:

• Polymer-based Coatings
• Polymer-free Coatings

Drug Eluting Stent Market, By Application:

• Coronary Artery Disease
• Peripheral Artery Disease

Drug Eluting Stent Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Eluting Stent Market.

Available Customizations:

Global Drug Eluting Stent market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Drug Eluting Stent Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings (Micro porous Surface, Micro structured Surface, Slotted tubular Surface, Nanoporous Surface))
  • 5.2.2. By Application (Coronary Artery Disease, Peripheral Artery Disease)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Drug Eluting Stent Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Coating Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Drug Eluting Stent Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Coating Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Drug Eluting Stent Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Coating Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Drug Eluting Stent Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Coating Type
      • 6.3.3.2.2. By Application

7. Europe Drug Eluting Stent Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Coating Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Drug Eluting Stent Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Coating Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Drug Eluting Stent Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Coating Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Drug Eluting Stent Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Coating Type
      • 7.3.3.2.2. By Application
  • 7.3.4. France Drug Eluting Stent Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Coating Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Drug Eluting Stent Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Coating Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Drug Eluting Stent Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Coating Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Drug Eluting Stent Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Coating Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Drug Eluting Stent Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Coating Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Drug Eluting Stent Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Coating Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Drug Eluting Stent Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Coating Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Drug Eluting Stent Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Coating Type
      • 8.3.5.2.2. By Application

9. South America Drug Eluting Stent Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Coating Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Drug Eluting Stent Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Coating Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Drug Eluting Stent Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Coating Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Drug Eluting Stent Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Coating Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Drug Eluting Stent Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Coating Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Drug Eluting Stent Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Coating Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Drug Eluting Stent Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Coating Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Drug Eluting Stent Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Coating Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Drug Eluting Stent Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Ltd.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Boston Scientific Corporation
• 14.3. Terumo Corporation
• 14.4. Medtronic plc
• 14.5. Biosensors International Ltd
• 14.6. Cook Medical pvt ltd.
• 14.7. B. Braun Medical (India) Private Limited
• 14.8. Biotronik, Inc.
• 14.9. Lepu Medical Technology Inc.

15. Strategic Recommendations

16. About Us & Disclaimer